Sharon E. Frey - Concepedia

Author

Sharon E. Frey

Also Known As

Ann R. Falsey, Carol Cole, Daniel Hoft, Karen Freudemann, Michelle DallaPiazza, Rebecca Rooks, Rittle, C., Robert J Epstein, S E FREY, S E Frey

179

Publications

7.4K

Citations

H-Index

Concepts

All Affiliations

Saint Louis University Emmes (United States)University of Maryland, Baltimore Baylor College of Medicine Duke University

About

Sharon E. Frey is an author at Saint Louis University specializing in medicine, vaccination, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	49	3.2K
2	Epidemiology	6	6	384
3	Public Health	5	5	294
4	Allergy	3	3	294
5	Cell Biology	1	1	41

Sharon E. Frey

108

Publications

6.9K

Citations

H-Index

Page 1

	Year	Citations
Clinical Responses to Undiluted and Diluted Smallpox Vaccine Sharon E. Frey, Robert B. Couch, Carol O. Tacket, New England Journal of Medicine	2002	261
Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults Sharon E. Frey, Michael Houghton, Stephen Coates, Vaccine VaccinationVaccine SafetyVaccinologyVaccine DevelopmentVaccine Research	2010	247
Adjuvanted Intranasal Norwalk Virus‐Like Particle Vaccine Elicits Antibodies and Antibody‐Secreting Cells That Express Homing Receptors for Mucosal and Peripheral Lymphoid Tissues Samer S. El‐Kamary, Marcela F. Pasetti, Paul M. Mendelman, The Journal of Infectious Diseases	2010	221
Dose-Related Effects of Smallpox Vaccine Sharon E. Frey, Frances K. Newman, John Cruz, New England Journal of Medicine	2002	182
Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles Paul A. Goepfert, Marnie Elizaga, Alicia Sato, The Journal of Infectious Diseases	2011	176
A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans John Lok Man Law, Chao Chen, Jason Wong, PLoS ONE VaccinationVaccine DevelopmentHepatitis CHepatitis C VirusViral Hepatitis	2013	174
Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 Mark K. Weng, Mona Doshani, Mohammed A. Khan, MMWR Morbidity and Mortality Weekly Report Hepatitis BAdvisory CommitteeVaccine HesitancyPreventive MedicineViral Hepatitis	2022	173
AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial Janet E. McElhaney, Jeanne‐Marie Devaster, Meral Esen, The Lancet Infectious Diseases VaccinationVaccine SafetyCross-protectionVaccinologyElderly People	2013	161
Clinical Efficacy of Cell Culture–Derived and Egg‐Derived Inactivated Subunit Influenza Vaccines in Healthy Adults Sharon E. Frey, Timo Vesikari, Agnieszka Szymczakiewicz‐Multanowska, Clinical Infectious Diseases	2010	158
Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects Sharon E. Frey, Anna Wald, Srilatha Edupuganti, Vaccine VaccinationMucosal VaccinationVaccine DevelopmentLyophilized Versus LiquidVaccinia Ankara	2015	145

Page 1